Salvato in:
Dettagli Bibliografici
Autore principale: Iskandar Idris
Natura: Artículo Open Access
Pubblicazione: Wiley 2024
Soggetti:
Accesso online:https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1002/doi2.89
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1867006218602545152
author Iskandar Idris
author_facet Iskandar Idris
Iskandar Idris
collection Wiley Open Access
contents Glucagon like peptide‐1 (GLP‐1) therapy is associated with reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes with chronic liver disease Iskandar Idris Diabetes, Obesity and Metabolism Now 10.1002/doi2.89 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/doi2.89
format Artículo Open Access
id wiley_oa_10_1002_doi2_89
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Glucagon like peptide‐1 (GLP‐1) therapy is associated with reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes with chronic liver disease
Iskandar Idris
Diabetes, Obesity and Metabolism Now
Glucagon like peptide‐1 (GLP‐1) therapy is associated with reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes with chronic liver disease Iskandar Idris Diabetes, Obesity and Metabolism Now 10.1002/doi2.89 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Glucagon like peptide‐1 (GLP‐1) therapy is associated with reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes with chronic liver disease
topic Diabetes, Obesity and Metabolism Now
url https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1002/doi2.89